Takayasu Arteritis with Dyslipidemia Increases Risk of Aneurysm

Lili Pan1, Juan Du1, Dong Chen2

  • 1Department of Rheumatology and Immunology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Scientific Reports
|October 3, 2019
PubMed

Insights

Elevated low-density lipoprotein cholesterol (LDL-C) significantly increases aneurysm risk in Takayasu arteritis (TAK) patients. This finding highlights LDL-C as a key factor in aneurysm development within this vasculitis population.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Clinical Lipidology

Background:

  • Low-density lipoprotein cholesterol (LDL-C) is a known risk factor for abdominal aortic aneurysms.
  • The association between elevated LDL-C and aneurysms in large vessel vasculitis, specifically Takayasu arteritis (TAK), remains under-investigated.
  • Understanding risk factors for aneurysm formation in TAK is crucial for patient management and preventative strategies.

Purpose of the Study:

  • To investigate the clinical and laboratory features of patients diagnosed with Takayasu arteritis (TAK).
  • To identify and analyze risk factors associated with the development of aneurysms in TAK patients.
  • To explore the specific role of elevated LDL-C levels in aneurysm formation within the TAK cohort.

Main Methods:

  • Retrospective study analyzing data from 103 patients with Takayasu arteritis (TAK).
  • Comparison of clinical manifestations, laboratory parameters, and imaging results between TAK patients with and without aneurysms.
  • Statistical analysis to identify risk factors for aneurysm formation, including LDL-C levels, disease duration, and erythrocyte sedimentation rate.

Main Results:

  • Aneurysms were identified in 20.4% of the studied TAK patients.
  • Patients with aneurysms exhibited significantly higher LDL-C levels compared to those without (2.9 ± 0.9 mmol/l vs. 2.4 ± 0.9 mmol/l, p=0.032).
  • Elevated LDL-C was associated with a 5.8-fold increased risk of aneurysm formation (p=0.021), with a cutoff value of 3.08 mmol/l.

Conclusions:

  • Elevated serum LDL-C levels are a significant risk factor for developing aneurysms in patients with Takayasu arteritis (TAK).
  • Longer disease duration (>5 years) and elevated erythrocyte sedimentation rate were also associated with increased aneurysm risk.
  • These findings underscore the importance of managing LDL-C levels in TAK patients to mitigate aneurysm development.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
738
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
290
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
259
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
843
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
176
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
424